PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran

EC / List no: 214-946-9 CAS no: 1222-05-5
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Information requested
Decision date
15-Nov-2023
Decision
Latest update
08-Mär-2024
Additional information
More information View
DEv 2
Scope
Comprehensive
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
DEv 3
Scope
Comprehensive
Status
Concluded
Decision date
31-Okt-2018
Decision
Latest update
26-Nov-2022
Additional information
More information View
DEv 4
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has stopped the assessment after the registrant(s) submitted new information.
More information View
DEv 5
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-Nov-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
France
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Year
2022
Status
Information requested
Conclusion document
Latest update
08-Mär-2024
More information View
PBT - Persistent, bioaccumulative and toxic assessment
PBT 1
Authority
France
Status
Under development
Outcome
Under development under SEV
Hazard assessment outcome document
Remarks
Concern
PBT (Article 57 d)
Date of intention
10-Okt-2017
Date of hazard assessment
Latest update
30-Jun-2022
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Under development
Outcome
Under development (other)
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
24-Sep-2018
Date of hazard assessment
Latest update
03-Feb-2021
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Intention
Date of intention
05-Okt-2023
Withdrawal date
Submitter
France
Proposed harmonised classification by the dossier submitter
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Reproductive toxicity
Endocrine disruptor for human health
Remarks
Date of opinion
RAC Opinion
Latest update
02-Apr-2024
More information View
Assessment of regulatory needs
ARN 1
Authority
ECHA
Concern
Status
Under development
Follow-up
CLH
SVHC
Pending action
Foreseen regulatory need
Restriction
Summary document
Group name
Fused tricyclic ethers with short chain polyalkyl substituents
Remarks
Date of intention
29-Aug-2022
Date of assessment
04-Mai-2023
Latest update
20-Sep-2023
More information View
ARN 2
Authority
France
Concern
Endocrine disruption
Status
Concluded
Follow-up
Other
Foreseen regulatory need
Summary document
Group name
Remarks
Date of intention
18-Dez-2018
Date of assessment
22-Jan-2020
Latest update
24-Nov-2021
More information View

List entry date: 13-Okt-2018

Export search results to: